Metabolism and disposition of gemfibrozil in Wistar and multidrug resistance-associated protein 2-deficient TR⁻ rats

References

• BALLATORI, N. and TRUONG, A. T., 1995, Multiple canalicular transport mechanisms for glutathione S-conjugates. Transport on both ATP- and voltage-dependent carriers. Journal of Biological Chemistry, 270, 3594–3601.
   PubMed Web of Science ®Google Scholar
• CHERRINGTON, N. J., HARTLEY, D. P., Li, N., JOHNSON, D. R. and KLAASSEN, C. D., 2002, Organ distribution of Multidrug resistance proteins 1, 2, and 3 (Mrpl, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. Journal of Pharmacology and Experimental Therapeutics, 300, 97–104.
   PubMed Web of Science ®Google Scholar
• CURTIS, C. G., DANAHER, T. M., HIBBERT, E. A., MORRIS, C. L., SCOTT, A. M., WOOLCOTT, B. A. and POWELL, G. M., 1985, The fate of gemfibrozil and its metabolites in the rat. Biochemical Society Transactions, 13, 1190–1191.
   Google Scholar
• DE VRIES, M. H., REDEGELD, F. A. M., KOSTER, A. S., NOORDHOEK, J., DE HANN, J. G. and OUDE ELFERINK, R. P. J., 1989, Hepatic, intestinal and renal transport of 1-naphthol-i3-D-glucuronide in mutant rats with hereditary-conjugated hyperbilirubinemia. Naunyn-Schmiedeberg's Archives of Pharmacology, 340, 588–592.
   Google Scholar
• DIETRICH, C. G., DE WAART, D. R., OTTENHOFF, R., BOOTSMA, A. H., VAN GENNIP, A. H. and OUDE ELFERINK, R. P. J., 2001a, Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1 -methy1-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis, 22, 805–811.
   PubMed Web of Science ®Google Scholar
• DIETRICH, C. G., DE WAART, D. R., OTTENHOFF, R., SCHOOTS, I. G. and OUDE ELFERINK, R. P. J., 2001 b, Increased bioavailability of the food-derived carcinogen 2-amino-l-methy1-6-phenylimidazo[4,5 -b]pyridine in Mrp2-deficient rats. Molecular Pharmacology, 59, 974–980.
   PubMed Web of Science ®Google Scholar
• DIX, K. J., COLEMAN, D. P. and JEEEcoAT, A. R., 1999, Comparative metabolism and disposition of gemfibrozil in male and female Sprague-Dawley rats and Syrian golden hamsters. Drug Metabolism and Disposition, 27, 138–146.
   PubMed Web of Science ®Google Scholar
• GERK, P. M. and VORE, M., 2002, Regulation of expression of the multidrug resistance associated protein 2 (MRP2) and its role in drug disposition. Journal of Pharmacology and Experimental Therapeutics, 302, 407–415.
   PubMed Web of Science ®Google Scholar
• HIROHASHI, T., ITo, K., OGAWA, K., SUZUKI, H., KUME, K., SHIMIZU, T. and SUGIYAMA, Y., 1998, Hepatic expression of multidrug resistance-associated protein (MRP)-like proteins maintained in Eisai hyperbilirubinemic rats (EHBR). Molecular Pharmacology, 53, 1068–1075.
   PubMed Web of Science ®Google Scholar
• HIROHASHI, T., Suzum, K. and SUGIYAMA, Y., 1999, Characterization of the transport properties of cloned rat multidrug resistance associated protein 3 (MRP3). Journal of Biological Chemistry, 274, 15181–15485.
   PubMed Web of Science ®Google Scholar
• ITO, S., IEmi, I., TANABE, M., SUZUKI, A., HIGUCHI, S. and OTSUBO, K., 2001, Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Phamcogenetics, 11, 175–184.
   PubMedGoogle Scholar
• JAGER, W., SARTORI, M., HERZOG, M. and THALHAMMER, T., 1998, Genistein metabolism in liver microsomes of Wistar and mutant TR- rats. Research Communications in Molecular Pathology and Pharmacology, 100, 105–116.
   PubMed Web of Science ®Google Scholar
• JANSEN, P. L. M., PERTERS, W. H. and LAMERS, W. H., 1985, Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology, 5, 573–579.
   Google Scholar
• KONIG, J., ROST, D., Cui, Y. and KEPPLER, D., 1999, Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology, 29, 1156–1163.
   PubMed Web of Science ®Google Scholar
• KUDO, N., KATAKU, M., SATO, Y. and KAWASHIMA, Y., 2002, Sex hormone-regulated renal transport of perfiuorooctanoic acid. Chemico-Biological Interactions, 139, 301–316.
   PubMed Web of Science ®Google Scholar
• KUSUHARA, H. and SUGIYAMA, Y., 2002, Role of transporters in the tissue-selective distribution and elimination of drugs: tranporters in the liver, small intestine, brain and kidney. Journal of Control Release, 78, 43–54.
   PubMed Web of Science ®Google Scholar
• MAYER, R., KARTENBECK, J., BUCHLER, M., JEDLITSCHKY, G., LEIER, I. and KEPPLER, D., 1995, Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence for the canalicular membrane in transport-deficient mutant hepatocytes. Journal of Cell Biology, 131, 137–150.
   PubMed Web of Science ®Google Scholar
• MOR-COHEN, R., ZIVELIN, A., ROSENBERG, N., SHANI, M., MUALLEM, S. and SELIGSOHN, U., 2001, Identification and functional analysis of two mutations in the Multidrug Resistance Protein 2 gene in Israeli patients with Dubin-Johnson syndrome. Journal of Biological Chemistry, 276, 36923–36930.
   PubMed Web of Science ®Google Scholar
• MOTTINO, A. D., HOFFMAN, T., JENNES, L., CAO, J. and VORE, M., 2001, Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats. American Journal of Physiology Gastrointestinal Liver Physiology, 280, G1261–G1273.
   Google Scholar
• NIINUMA, K., TAKENAKA, 0., HORIE, T., KOBAYASHI, K., KATO, Y., SIZUKI, H. and SUGIYAMA, Y., 1997, Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2-4-dinitropheny1)-glutathione and 6-hydroxy-5,7-dimethy1-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide. Journal of Pharmacology and Experimental Therapeutics, 282, 866–872.
   Google Scholar
• NISHIDA, T., GATMAITAN, Z., CHOWDHRY, R. and ARIAS, I. M., 1992, Two distinct mechanisms for bilirubin glucuronide transport by rat bile canalicular membrane vesicles. Demonstration of defective ATP-dependent transport in rats (TR-) with inherited conjugated hyperbilirubinemia. Journal of Clinical Investigation, 90, 2130–2135.
   Google Scholar
• OGAWA, K., SUZUKI, H., HIROHASHI, T., ISHIKAWA, T., MEIER, P. J., HIROSE, K., AKIZAWA, T., YOSHIOKA, M. and SUGIYAMA, Y., 2000, Characterization of inducible nature of MRP3 in rat
   Google Scholar
• LIVER. American Journal of Physiology Gastrointestinal Liver Physiology, 278, G438–G446.
   Google Scholar
• OKERHOLM, R. A., KEELEY, F. J., PETERSON, F. E. and GLAZKO, A. J., 1976, The metabolism of gemfibrozil. Proceedings of Royal Society of Medicine, 69 (Suppl. 2), 11–14.
   PubMedGoogle Scholar
• OUDE ELFERINK, R. P. J. and JANSEN, P. L. M., 1994, The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. Pharmacology and Therapeutics, 64, 77–97.
   Google Scholar
• PAULUSMA, C. C., BOSMA, P. J., ZAMAN, G. J. R., BARKER, C. T. M., OTTER, M., SCHEFFER, G. L. and SCHEPER, R. J., 1996, Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science, 271, 1126–1128.
   Google Scholar
• PAULUSMA, C. C., KOOL, M., BOSMA, P. J., SCHEFFER, G. L., TER BORG, F., SCHEPER, R. J., TYTGAT, G. N. J., BORST, P., BAAS, F. and OUDE ELFERINK, R. P. J., 1997, A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson Syndrome. Hepatology, 25, 1539–1542.
   Google Scholar
• PAULUSMA, C. C. and OUDE ELFERINK, R. P. J., 1997, The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man. Journal of Molecular Medicine, 75, 420–428.
   PubMed Web of Science ®Google Scholar
• PRUEKSARITANONT, T., ZHAO, J. J., BENNET, M., ROADCAP, B. A., TANG, C., QIU, Y., Liu, L., LIN, J. H., PEARSON, P. G. and BAILLIE, T. A., 2002, Mechanistic studies on metabolic interactions between gemfibrozil and statins. Journal of Pharmacology and Experimental Therapeutics, 301, 1042–1051.
   PubMed Web of Science ®Google Scholar
• RAUCY, J. L. and LASKER, J. M., 1991, Purification of P450 enzymes from human liver. In E. F. John and M. R. Waterman (eds), Methods in Enzymology: Cytochrome P450 (San Diego: Academic Press), 577–587.
   Google Scholar
• RENES, J., DE VRIES, E. G. E., JANSEN, P. L. M. and MULLER, M., 2000, The (patho) physiological functions of the MRP family. Drug Resistance Updates, 3, 289–302.
   Google Scholar
• SALLUSTIO, B. C., SABORDO, L., EVANS, A. M. and NATION, R. L., 2000, Hepatic disposition of electrophilic acyl glucuronide conjugates. Current Drug Metabolism, 1, 163–180.
   PubMed Web of Science ®Google Scholar
• SCHAUB, T. P., KARTENBECK, J., KONIG, J., VOGEL, 0., WITZGALL, R., KRIZ, W. and KEPPLER, D., 1997, Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. Journal of the American Society of Nephrology, 8, 1213–1221.
   Google Scholar
• SMITH, P. K., KROHN, R. I., HERMANSON, G. T., MALLIA, A. K., GARTNER, F. H., PROVENZANO, M. D., FUJIMOTO, E. K., GOEKE, N. M., OLSON, B. J. and KLENK, D. C., 1985, Measurement of protein using bicinchoninic acid. Analytical Biochemistry, 150, 76–85.
   PubMed Web of Science ®Google Scholar
• SPAHN-LANGGUTH, H. and BENET, L., 1992, Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism. Drug Metabolism Review, 24, 5–48.
   PubMed Web of Science ®Google Scholar
• ST-PIERRE, M. V., SERRANO, M. A., MACIAS, R. I., DUBS, U., HOECHLI, M., LAUPER, U., MEIER, P. J. and MARIN, J. J., 2000, Expression of members of the multidrug resistance protein family in human term placenta. American Journal of Physiology Regulatory Integrative and Comparative Physiology, 279, R1495–R1503.
   Google Scholar
• THOMAS, B. F., BURGESS, J. P., COLEMAN, D. P., SCHEFFLER, N. M., JEFFCOAT, A. R. and Dix, K. J., 1999, Isolation and identification of novel metabolites of gemfibrozil in rat urine. Drug Metabolism and Disposition, 27, 147–157.
   Google Scholar
• TODD, P. A. and WARD, A., 1988, Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia. Drugs, 36, 314–339.
   PubMed Web of Science ®Google Scholar
• VAN AUBEL, R. A. M. H., MASEREEUW, R. and RUSSEL, F. G. M., 2000, Molecular pharmacology of renal organic anion transporters. American Journal of Physiology and Renal Physiology, 279, F216–F232.
   Google Scholar
• WADA, M., TOH, S., TANIGUCHI, K., NAKAMURA, T., UCHIUMI, T., KOHNO, K., YOSHIDA, I., KIMURA, A., SAKISAKA, S., ADACHI, Y. and KUWANO, M., 1998, Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Human Molecular Genetics, 7, 203–207.
   PubMed Web of Science ®Google Scholar
• XIONG, H., TURNER, K. C., WARD, E. S., JANSEN, P. L. M. and BROUWER, K. L. R., 2000, Altered hepatobiliary disposition of acetoaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR- rats. Journal of Pharmacology and Experimental Therapeutics, 295, 512–518.
   Google Scholar